Carregant...
Monoclonal antibody as an emerging therapy for acute ischemic stroke
Acute ischemic stroke (AIS) is the 5(th) leading cause of death and the leading cause of neurological disability in the United States. The oxygen and glucose deprivation associated with AIS not only leads to neuronal cell death, but also increases the inflammatory response, therefore decreasing the...
Guardat en:
| Publicat a: | Int J Physiol Pathophysiol Pharmacol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
e-Century Publishing Corporation
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7486556/ https://ncbi.nlm.nih.gov/pubmed/32934765 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|